Skip to main content
. 2016 Sep 28;4:e2478. doi: 10.7717/peerj.2478

Table 11. The genes targeted by the 30 potential drugs.

NPC1 (20) U IL1B (14) U PPP3CA (10) U HSPA1A (4) U PTBP1 (3) U
CYP51A1 (2) U RNASEH1 (1) U CDK19 (1) U AKT3 (1) U INSR (1) U
TP53 (23) D ADRB2 (23) D RGS4 (22) D SMPD1 (17) D POLI (17) D
BAZ2B (15) D MMP14 (15) D BCL2L1 (15) D NR2F2 (14) D SUMO1 (14) D
VIPR1 (10) D EGFR (10) D ID4 (9) D RXRA (7) D PLEC (5) D
NLRP1 (5) D STAT1 (4) D WEE1 (4) D STK3 (3) D SRPK1 (3) D
SGK1 (3) D MKNK2 (3) D DUSP1 (2) D PLAU (1) D CDC42BPA (1) D
CDK2 (1) D KDR (1) D SIK1 (1) D

Note:

The parentheses represent the number of associated cMap drugs, U and D represent up and down-regulated respectively.